Hostname: page-component-cd9895bd7-gxg78 Total loading time: 0 Render date: 2024-12-26T03:27:17.308Z Has data issue: false hasContentIssue false
  • English
  • Français

The epidemiology of substance misuse and comorbid psychiatric disorders

Published online by Cambridge University Press:  24 June 2014

Mohammed T Abou-Saleh  and
Aleksandar Janca
Mohammed T Abou-Saleh*
Affiliation:
Reader & Honorary Consultant in Addiction Psychiatry, St George's Hospital Medical School, University of London, UK
Aleksandar Janca
Affiliation:
University of Western Australia, School of Psychiatry and Clinical Neurosciences, Australia
*
Dr M T Abou-Saleh, Addiction Services, Director of Research and Development, South-West London and St George's NHS Trust, Cranmer Terrace, London SW17 0RE, UK. Tel: 020 87250368; Fax: 020 87252914; Email: mabousal@sghms.ac.uk
Get access Rights & Permissions [Opens in a new window]

Abstract

The common co-occurrence of substance misuse and other psychiatric disorders and their intricate relationships have led to major community-based epidemiological studies in the US which showed high rates of current and lifetime comorbidity. Moreover, studies of clinical populations conducted in North America, Europe and Australia, showed even higher rates of comorbidity. The aetology of this comorbidity has also been investigated and important models have emerged with findings that inform its assessment and treatment. Future epidemiological studies should focus on the study of concurrent conditions rather than lifetime ones using research diagnostic instruments with high reliability providing information on a number of key outcomes.

Keywords

comorbidityepidemologysubstance misuse
Type
Research Article
Information
Acta Neuropsychiatrica , Volume 16 , Issue 1 , February 2004 , pp. 3 - 8
Copyright
Copyright © 2004 Blackwell Munksgaard

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Reiger, DA, Myers, JK, Kramer, Met al. The NIMH Epidemiologic Catchment Area program. Historical context, major objectives, and study population characteristics. Arch Gen Psychiatry 1984;41: 934–941.CrossRefGoogle Scholar
Kessler, RC, McGonagle, KA, Zhao, Set al. Lifetime and 12 month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Co morbidity Survey. Arch Gen Psychiatry 1994;51: 8–19.CrossRefGoogle Scholar
Grant, BF. Co morbidity between DSM-1V drug use disorders and major depression: results of a national survey of adults. J Subst Abuse 1995;7: 481–497.CrossRefGoogle Scholar
Bland, RC, Newman, SC, Russell, JMet al. (eds). Epidemiology of psychiatric disorders in Edmonton: Phenomenology and comorbidity. Acta Psychiatr Scand 1994; 89 (Suppl. 376):5–70. CrossRefGoogle Scholar
Schifano, F.European dimensions of dual diagnosis. In: Rassool, GH (ed). Dual Diagnosis: Substance Misuse and Psychiatric Disorders. Oxford, UK: Blackwell Science Ltd, 2002, pp 58–65. Google Scholar
Farrell, M, Howes, S, Taylor, Cet al. Substance misuse and psychiatric comorbidity: an overview of the OPCS national psychiatric morbidity survey. Addict Behav 1998;23: 909–918.CrossRefGoogle ScholarPubMed
Gossop, M, Marsden, J, Stewart, Det al. Substance use, health and social problems of service users at 54 drug treatment agencies. Intake data from the National Treatment Outcome Research Study. Br J Psychiatry 1998;173: 166–171.CrossRefGoogle ScholarPubMed
Menezes, POR, Johnson, S, Thornicroft, Get al. Drug and Alcohol Problems among Individuals with Severe Mental Illnesses in South London. Br J Psychiatry 1996;168: 612–619.CrossRefGoogle ScholarPubMed
Glass, IB, Jackson, P. Maudsley Hospital Survey: prevalence of alcohol problems and other psychiatric disorders in a hospital population. Br J Addict 1998;83: 1105–1111. CrossRefGoogle Scholar
Cantwell, R, Brewin, J, Glazebrook, Cet al. Prevalence of substance misuse in first episode psychosis. Br J Psychiatry 1999;174: 150–153.CrossRefGoogle ScholarPubMed
Graham, HL, MASLIN, J, Copello, Aet al. Drug and alcohol problems amongst individuals with severe mental health problems in an inner city area of the UK. Soc Psychiatry Psychiatr Epidemiol 2001;36: 448–455.CrossRefGoogle Scholar
Henderson, S, Andrews, G, Hall, W. Australia's mental health: an overview of the general population survey. Aust N Z J Psychiatry 2000;34: 197–205.CrossRefGoogle ScholarPubMed
Tesson, M, Hall, W, Lynskey, M, Degenhardt, L. Alcohol-and drug-use disorders in Australia: implications of the National Survey of Mental Health and Wellbeing. Aust N Z J Psychiatry 2000;34: 206–213.CrossRefGoogle Scholar
Maslin, J. Substance misuse in psychosis: contextual issues. In: Graham, HL, Copello, A, Birchwood, M, Muser, KT (eds). Substance misuse in psychosis: approaches to treatment and service delivery. Chichester, UK: John Wiley & Sons Ltd, 2003, pp 3–23. Google Scholar
Hasin, D, Trautman, KMS, Endicott, J. Psychiatric research interview for substance and mental disorders: phenomenologically based diagnosis in patients who abuse alcohol or drugs. Psychopharmacol Bull 1998;34: 3–8.Google ScholarPubMed
Weaver, T, Madden, P, Charles, Vet al. Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. Br J Psychiatry 2003;183: 304–313.CrossRefGoogle ScholarPubMed
Drake, RE, Rosenberg, SD, Mueser, KT. Assessing substance use disorder in persons with severe mental illness. New Dir Ment Health Serv 1996;70: 3–17.CrossRefGoogle Scholar
Ghodse, AH. Drugs and Addictive behaviour: a guide to treatment (2nd Edition). Oxford, UK: Blackwell Sciences Ltd, 1995. Google Scholar
Brooner, RK, King, VL, Kidorf, M, Schmidt, CW, Jr., Bigelow, GE. Psychiatric disorders. In: Kranzler, HR, Rounsaville, BJ (eds). Dual diagnosis and treatment. New York, USA: Marcel Dekker Inc, 1998, pp 1–25. Google Scholar
Verheul, R, Kranzler, HR, Polingt, J, Tenne, H, Ball, S, Rounsaville, BJ. Co-occurrence of Axis 1 and Axis II disorders in substance abusers. Acta Psychiatr Scand 2000;101: 110–118.CrossRefGoogle Scholar
Dixon, L, McNary, S, Lehman, AF. Remission of substance use disorder among psychiatric inpatients with mental illness. Am J Psychiatry 1998;155: 239–243.Google ScholarPubMed
Appleby, L, Shaw, J, Amos, Tet al. Suicide within 12 months of contact with mental health services: national clinical survey. BMJ 1999;318: 1235–1239.CrossRefGoogle ScholarPubMed
Oyefeso, A, Ghodse, H, Clancy, C, Corkery, JM. Suicide among drug addicts in the UK. Br J Psychiatry 1999;175: 277–282.CrossRefGoogle ScholarPubMed
Mueser, KT, Bellack, AS, Blanchard, JJ. Comorbidity of schizophrenia and substance abuse: implications for treatment. J Consult Clin Psychol 1998;60: 845–856. CrossRefGoogle ScholarPubMed
Mueser, KT, Yarnold, PR, Rosenberg, SD, Swett, CJr, Miles, KM, Hill, D. Substance Use Disorders in Hospitalised Severely Mentally Ill Psychiatric Patients: Prevalence, Correlates, and Subgroups. Schizophr Bull 2000;26: 179–192.CrossRefGoogle Scholar
Scheller-Gilkey, G, Lewine, RR, Caudle, J, Brown, FW. Schizophrenia, substance use, and brain morphology. Schizophr Res 1999;35: 113–120.CrossRefGoogle ScholarPubMed
Hasin, DS, Nunes, EV. Comorbidity of alcohol, drug and psychotic disorders. In: Kranzler, HR, Rounsaville, BJ (eds). Dual diagnosis and treatment. New York, USA: Marcel Dekker Inc., 1998, pp 1–30. Google Scholar
Prince, M, Stewart, R, Ford, T, Hotopf, M. Psychiatric epidemiology – looking to the future in practical psychiatric epidemiology. Oxford, UK: Oxford University Press, 2003. Google Scholar
Abou-Saleh, MT. Al Ain community psychiatric survey. I. Prevalence and socio-demographic correlates. Soc Psychiatry Psychiatr Epidemiolol 2001;36: 20–28. CrossRefGoogle Scholar